EnVVeno has first-in-human heart valve data, expects FDA decision this year
May 14, 2025
EnVVeno Medical (Nasdaq:NVNO) announced three-year outcomes for its heart valve that it aims to submit to the FDA this year.
EnVVeno Medical (Nasdaq:NVNO) announced three-year outcomes for its heart valve that it aims to submit to the FDA this year.
Terumo Neuro (formerly MicroVention) announced that it launched its Sofia 88 neurovascular support catheter in the U.S.